169814-53-3 Usage
Description
Ethanone, 1-[3-(4-bromophenyl)-5-methyl-4-isoxazolyl]-, also known as 5-bromo-3-(4-bromophenyl)-1-methyl-1,2-oxazol-4(5H)-one, is a chemical compound with the molecular formula C11H10BrNO2. It is a derivative of isoxazole and is characterized by its unique structure and diverse biological activities.
Uses
Used in Pharmaceutical Industry:
Ethanone, 1-[3-(4-bromophenyl)-5-methyl-4-isoxazolyl]is used as an intermediate in the synthesis of pharmaceuticals for its potential therapeutic applications. Its antimicrobial, antifungal, and herbicidal properties make it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, Ethanone, 1-[3-(4-bromophenyl)-5-methyl-4-isoxazolyl]is used as a key component in the formulation of various agrochemical products. Its herbicidal properties contribute to the development of effective weed control solutions.
Used in Disease Treatment Research:
Ethanone, 1-[3-(4-bromophenyl)-5-methyl-4-isoxazolyl]is also used in research for the potential treatment of certain diseases. Its diverse biological activities make it a promising candidate for further investigation and development in the medical field.
It is important to handle and use Ethanone, 1-[3-(4-bromophenyl)-5-methyl-4-isoxazolyl]with caution due to its potential hazards and health risks. Proper safety measures should be taken to minimize any risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 169814-53-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,8,1 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 169814-53:
(8*1)+(7*6)+(6*9)+(5*8)+(4*1)+(3*4)+(2*5)+(1*3)=173
173 % 10 = 3
So 169814-53-3 is a valid CAS Registry Number.
169814-53-3Relevant articles and documents
Aryl-isoxazol-4-yl-imidazole derivatives
-
Page/Page column 20, (2010/11/28)
The present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula I: wherein R1 to R6 are as defmed in the specification and pharmaceutically acceptable acid addition salts thereof. This class of compounds h
